UBS has completed the bank deal backing GTCR Golder Rauner's investment in NewQuest Health Solutions, a managed care organization. The $180 million facility consists of a $165 million term loan priced at LIBOR plus 3% and a $15 million revolver priced at LIBOR plus 3 1/4%. The deal was oversubscribed and pricing was reverse flexed 25 basis points from LIBOR plus 3 1/4% to LIBOR plus 3%.
"When it came to NewQuest, the deal was very well received by the market," a banker said. "I think the dynamics behind the free cash flow as well as a strong sponsorship from GTCR was received with much fanfare." Joe Nolan, a GTCR principal, referred questions to UBS.